These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37822407)

  • 41. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents.
    Nishijima S; Kurokawa I; Kawabata S
    J Int Med Res; 1996; 24(6):473-7. PubMed ID: 8959531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria.
    Owen L; Grootveld M; Arroo R; Ruiz-Rodado V; Price P; Laird K
    Phytother Res; 2017 Mar; 31(3):410-417. PubMed ID: 28124400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
    Gloor M; Wasik B; Becker A; Höffler U
    Dermatology; 2002; 205(3):260-4. PubMed ID: 12399674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resistance of propionibacteria to antibiotics used in the treatment of acne.
    Brown JM; Poston SM
    J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure.
    Eady EA; Cove JH; Holland KT; Cunliffe WJ
    Br J Dermatol; 1989 Jul; 121(1):51-7. PubMed ID: 2527056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes.
    Crawford WW; Crawford IP; Stoughton RB; Cornell RC
    J Invest Dermatol; 1979 Apr; 72(4):187-90. PubMed ID: 429800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes.
    Lim YH; Kim IH; Seo JJ
    J Microbiol; 2007 Oct; 45(5):473-7. PubMed ID: 17978809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibiotic resistance in the topical treatment of acne vulgaris.
    Leyden JJ
    Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison effect of azithromycin gel 2% with clindamycin gel 1% in patients with acne.
    Mokhtari F; Faghihi G; Basiri A; Farhadi S; Nilforoushzadeh M; Behfar S
    Adv Biomed Res; 2016; 5():72. PubMed ID: 27169103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nasal antibiotic-resistant Propionibacterium acnes carriage in acne vulgaris patients in Turkey.
    Ergin C; Ergin S; Kaleli I; Kaçar N; Sengül M; Erdoğan BS
    J Dermatol; 2006 Dec; 33(12):899-901. PubMed ID: 17169100
    [No Abstract]   [Full Text] [Related]  

  • 51. Long-term administration of oral macrolides for acne treatment increases macrolide-resistant Propionibacterium acnes.
    Nakase K; Okamoto Y; Aoki S; Noguchi N
    J Dermatol; 2018 Mar; 45(3):340-343. PubMed ID: 29235673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multidrug Resistance Plasmid pTZC1 Could Be Pooled among
    Koizumi J; Nakase K; Hayashi N; Takeo C; Nakaminami H
    Microbiol Spectr; 2023 Feb; 11(2):e0362822. PubMed ID: 36847559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial activity of topical agents against Propionibacterium acnes: an in vitro study of clinical isolates from a hospital in Shanghai, China.
    Ma Y; Zhang N; Wu S; Huang H; Cao Y
    Front Med; 2016 Dec; 10(4):517-521. PubMed ID: 27896620
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Bacterial resistance in acne? A meta-analysis of the controversy].
    Alvarez-Sánchez M; Rodríguez-Ayala E; Ponce-Olivera RM; Tirado-Sánchez A; Arellano-Mendoza MI
    Cir Cir; 2016; 84(3):190-5. PubMed ID: 26738649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clonality and anatomic distribution on the skin of antibiotic resistant and sensitive Propionibacterium acnes.
    Lomholt HB; Kilian M
    Acta Derm Venereol; 2014 Sep; 94(5):534-8. PubMed ID: 24577497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm.
    Oprica C; Emtestam L; Lapins J; Borglund E; Nyberg F; Stenlund K; Lundeberg L; Sillerström E; Nord CE
    Anaerobe; 2004 Jun; 10(3):155-64. PubMed ID: 16701513
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibiotic resistance of microbial strains isolated from Korean acne patients.
    Moon SH; Roh HS; Kim YH; Kim JE; Ko JY; Ro YS
    J Dermatol; 2012 Oct; 39(10):833-7. PubMed ID: 22779738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Propionibacterium acnes resistance to antibiotics in acne patients.
    Leyden JJ; McGinley KJ; Cavalieri S; Webster GF; Mills OH; Kligman AM
    J Am Acad Dermatol; 1983 Jan; 8(1):41-5. PubMed ID: 6219134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic antibiotic therapy of acne vulgaris.
    Ochsendorf F
    J Dtsch Dermatol Ges; 2006 Oct; 4(10):828-41. PubMed ID: 17010172
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topical clindamycin in the management of acne vulgaris.
    Guay DR
    Expert Opin Pharmacother; 2007 Oct; 8(15):2625-64. PubMed ID: 17931096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.